Lidds
在场
Lidds 是一家在股票代码 LIDDS (SE) 下上市的公司。
高管
查看带有其 6 名主要高管的组织结构图
Lidds 搜索最多的简介
- Jenni Björnulfson, Director, Chief Executive Officer, Chief Finan...
- Daniel Lifveredson, Chairman of the Board
- Torbjörn Browall, Director
创建提醒
跟踪 Lidds 的高管变动
药店
Lidds 拥有 1,840 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
- Grace Therapeutics将在Oct 25, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
药店 行业的其他推荐联系人
消息
Lidds 的最新新闻稿
- LIDDS patent covering the NanoZolid® production process granted in Russia and Australia - Lidds
- LIDDS patent covering the NanoZolid® production process granted in Russia and Australia - Lidds
- LIDDS Interim report Jan – Jun 2021 - Lidds
- LIDDS – subscription of warrants - Lidds
- LIDDS carry out a directed share issue of and is provided with approximately MSEK 45 - Lidds
- LIDDS genomför en riktad nyemission av aktier och tillförs cirka 45 Mkr - Lidds
- LIDDS Announces Appointment of Jenni Björnulfson as New Chief Financial Officer - Lidds
- LIDDS new CEO will present at Redeye’s Growth Day and Aktiespararna’s Småbolagsdagarna - Lidds
- LIDDS intends to carry out a directed share issue of approximately MSEK 45 - Lidds
- LIDDS intends to carry out a directed share issue of approximately MSEK 45 - Lidds
- View more press releases Close
关于 Lidds 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Jenni Björnulfson 
